Angiotensin II Type 1 Receptor Overexpression in Podocytes Induces Glomerulosclerosis in Transgenic Rats
- 1 June 2004
- journal article
- research article
- Published by American Society of Nephrology (ASN) in Journal of the American Society of Nephrology
- Vol. 15 (6) , 1475-1487
- https://doi.org/10.1097/01.asn.0000127988.42710.a7
Abstract
Angiotensin II (AngII) is a critical determinant of glomerular function involving both hemodynamic and pressure-independent effects that are insufficiently understood. A novel transgenic rat (TGR) model with overexpression of the human AngII type 1 receptor (hAT1) in podocytes was developed to study the consequences of an increased AT1 signaling on the structure and function of the glomerular filter. Use of the nephrin promoter to target the podocytes resulted in an expression of the hAT1 at a level roughly two times higher than the endogenous AT1 throughout life. All male TGR developed significant albuminuria starting at 8 to 15 wk of age; systolic BP was not elevated. More or less concurrently, structural changes at the glomerulus were encountered, starting with ubiquitous formation of pseudocysts at podocytes, followed by foot process effacement and local detachments. This damage progressed to nephron loss via the well known pathway typical for classic focal segmental glomerulosclerosis. The structural changes significantly correlated with age (r2 = 0.76) and urinary albumin excretion (r2 = 0.70). The data provide direct evidence that increased AT1 signaling in podocytes leads to protein leakage and structural podocyte damage progressing to focal segmental glomerulosclerosis.Keywords
This publication has 19 references indexed in Scilit:
- Cytoskeletal Reorganization by Mycophenolic Acid Alters Mesangial Cell Migration and ContractilityHypertension, 2003
- Two Gene Fragments that Direct Podocyte-Specific Expression in Transgenic MiceJournal of the American Society of Nephrology, 2002
- Overexpression of the human angiotensin II type 1 receptor in the rat heart augments load induced cardiac hypertrophyJournal of Molecular Medicine, 2001
- Renoprotective benefits of RAS inhibition: From ACEI to angiotensin II antagonistsKidney International, 2000
- Reduced growth, abnormal kidney structure, and type 2 (AT 2 ) angiotensin receptor-mediated blood pressure regulation in mice lacking both AT 1A and AT 1B receptors for angiotensin IIProceedings of the National Academy of Sciences, 1998
- Progression of glomerular diseases: Is the podocyte the culprit?Kidney International, 1998
- Angiotensin II Induction of Neurite Outgrowth by AT2 Receptors in NG108-15 CellsJournal of Biological Chemistry, 1996
- Effects of Losartan on Renal Function in Patients with Essential HypertensionJournal of Cardiovascular Pharmacology, 1996
- Mitogen-activated Protein Kinases in Rat Brain Neuronal Cultures Are Activated by Angiotensin II Type 1 Receptors and Inhibited by Angiotensin II Type 2 ReceptorsJournal of Biological Chemistry, 1996
- The angiotensin II type 2 (AT2) receptor antagonizes the growth effects of the AT1 receptor: gain-of-function study using gene transfer.Proceedings of the National Academy of Sciences, 1995